Display options
Share it on

Front Cardiovasc Med. 2015 Feb 23;2:6. doi: 10.3389/fcvm.2015.00006. eCollection 2015.

Central Sympathetic Activation and Arrhythmogenesis during Acute Myocardial Infarction: Modulating Effects of Endothelin-B Receptors.

Frontiers in cardiovascular medicine

Theofilos M Kolettis, Marianthi Kontonika, Eleonora Barka, Evangelos P Daskalopoulos, Giannis G Baltogiannis, Christos Tourmousoglou, Apostolos Papalois, Zenon S Kyriakides

Affiliations

  1. Cardiovascular Research Institute , Ioannina and Athens , Greece.
  2. Cardiovascular Research Institute , Ioannina and Athens , Greece ; Experimental Research Center ELPEN , Athens , Greece.

PMID: 26664878 PMCID: PMC4671362 DOI: 10.3389/fcvm.2015.00006

Abstract

Sympathetic activation during acute myocardial infarction (MI) is an important arrhythmogenic mechanism, but the role of central autonomic inputs and their modulating factors remain unclear. Using the in vivo rat-model, we examined the effects of clonidine, a centrally acting sympatholytic agent, in the presence or absence of myocardial endothelin-B (ETB) receptors. We studied wild-type (n = 20) and ETB-deficient rats (n = 20) after permanent coronary ligation, with or without pretreatment with clonidine. Cardiac rhythm was continuously recorded for 24 h by implantable telemetry devices, coupled by the assessment of autonomic and heart failure indices. Sympathetic activation and arrhythmogenesis were more prominent in ETB-deficient rats during the early phase post-ligation. Clonidine improved these outcomes throughout the observation period in ETB-deficient rats, but only during the delayed phase in wild-type rats. However, this benefit was counterbalanced by atrioventricular conduction abnormalities and by higher incidence of heart failure, the latter particularly evident in ETB-deficient rats. Myocardial ETB-receptors attenuate the arrhythmogenic effects of central sympathetic activation during acute MI. ETB-receptor deficiency potentiates the sympatholytic effects of clonidine and aggravates heart failure. The interaction between endothelin and sympathetic responses during myocardial ischemia/infarction and its impact on arrhythmogenesis and left ventricular dysfunction merits further investigation.

Keywords: acute myocardial infarction; endothelin receptors; sympathetic activation; ventricular arrhythmias

References

  1. J Cardiovasc Pharmacol. 1985 Nov-Dec;7(6):1176-82 - PubMed
  2. Expert Rev Cardiovasc Ther. 2009 Jul;7(7):723-5 - PubMed
  3. J Neurosci. 1981 Aug;1(8):908-17 - PubMed
  4. Cardiovasc Res. 2005 Sep 1;67(4):647-54 - PubMed
  5. Life Sci. 2014 Nov 24;118(2):165-72 - PubMed
  6. J Cell Commun Signal. 2010 Mar;4(1):51-62 - PubMed
  7. Cardiol Rev. 2013 Sep-Oct;21(5):249-56 - PubMed
  8. Heart Rhythm. 2008 Jan;5(1):131-9 - PubMed
  9. Eur J Pharmacol. 2008 Feb 2;580(1-2):241-9 - PubMed
  10. Pharmacol Res. 2010 Dec;62(6):489-99 - PubMed
  11. Basic Res Cardiol. 2010 Mar;105(2):235-45 - PubMed
  12. Hypertension. 2002 Jan;39(1):63-8 - PubMed
  13. J Cardiovasc Risk. 2000 Jun;7(3):163-75 - PubMed
  14. Neuroscience. 2004;124(4):719-23 - PubMed
  15. Cardiol Res Pract. 2012;2012:986813 - PubMed
  16. Br J Pharmacol. 2002 Feb;135(3):807-15 - PubMed
  17. J Clin Invest. 2000 Apr;105(7):925-33 - PubMed
  18. Curr Opin Pharmacol. 2013 Apr;13(2):210-7 - PubMed
  19. Clin Exp Pharmacol Physiol. 2006 Apr;33(4):327-31 - PubMed
  20. PLoS One. 2008 Aug 27;3(8):e3071 - PubMed
  21. Eur J Pharmacol. 2007 Jun 14;564(1-3):150-7 - PubMed
  22. Am J Physiol. 1997 Nov;273(5 Pt 2):H2240-7 - PubMed
  23. Neurosci Lett. 1989 Feb 27;97(3):276-9 - PubMed
  24. J Pharmacol Exp Ther. 1989 Oct;251(1):27-38 - PubMed
  25. Circ Res. 1992 Nov;71(5):1078-87 - PubMed
  26. Eur Heart J. 1991 Dec;12 Suppl F:38-47 - PubMed
  27. Heart Rhythm. 2005 Oct;2(10):1122-7 - PubMed
  28. Clin Auton Res. 2003 Oct;13(5):339-41 - PubMed
  29. Heart Rhythm. 2011 Dec;8(12):1963-8 - PubMed
  30. Europace. 2007 Nov;9(11):1099-104 - PubMed
  31. Cardiovasc Res. 1998 Jul;39(1):194-215 - PubMed
  32. Basic Res Cardiol. 2007 Mar;102(2):154-62 - PubMed
  33. J Basic Clin Physiol Pharmacol. 2014 May 1;25(2):143-53 - PubMed
  34. J Cardiovasc Pharmacol. 1988;12 Suppl 1:S1-7 - PubMed
  35. Cardiovasc Res. 1993 Nov;27(11):1954-60 - PubMed
  36. Life Sci. 2014 Nov 24;118(2):136-40 - PubMed
  37. Neuroscience. 1999;91(3):1067-75 - PubMed
  38. Circulation. 2005 Jan 25;111(3):302-9 - PubMed
  39. Clin Sci (Lond). 2007 Jun;112(7):385-91 - PubMed
  40. Circ Res. 1991 May;68(5):1204-15 - PubMed
  41. J Physiol. 2005 May 15;565(Pt 1):325-33 - PubMed
  42. J Am Coll Cardiol. 2010 Feb 16;55(7):637-42 - PubMed
  43. Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1010-116 - PubMed
  44. Pharmacol Ther. 2013 Aug;139(2):213-48 - PubMed
  45. Comput Methods Programs Biomed. 2004 Oct;76(1):73-81 - PubMed
  46. Cardiovasc Res. 2005 Aug 1;67(2):283-90 - PubMed
  47. Eur J Pharmacol. 2008 Sep 4;591(1-3):182-8 - PubMed
  48. Anesth Analg. 1999 Jul;89(1):159-62 - PubMed
  49. Circulation. 1995 Jul 15;92(2):253-61 - PubMed
  50. Br J Pharmacol. 2005 Jul;145(5):551-64 - PubMed
  51. Life Sci. 2014 Nov 24;118(2):281-7 - PubMed
  52. Cardiol Res Pract. 2012;2012:789071 - PubMed

Publication Types